dr. christof veit neuer geschaeftsführer der bundesgeschaeftsstelle qualitaetssicherung (bqs)

1
Medicine National Roundtable on Health Care Quality. JAMA 1998;280:1000–5. [20] Ottorino C, Kimberly H, Carlson MD, Boyd K, Buchter CM, Raiz P, et al. Impact of a Guideline-Based Disease Management Team on Outcomes of Hospitalized Patients With Congestive Heart Failure. Arch Intern Med. 2001;161:177–82. [21] Galbreath AD, Krasuski RA, Smith B, Stajduhar KC, Kwan MD, Ellis R, et al. Long-Term Healthcare and Cost Outcomes of Disease Management in a Large, Ran- domized, Community-Based Population With Heart Failure. Circ. 2004;110: 3518–26. [22] Lieberman SM, Lee J, Anderson T, Crippen DL. Reducing the growth of Medicare spending: geographic versus patient-based strategies. Health Affairs. Web Exclusive. 10 December 2003. W3-603-613. Acces- sed at http://content.healthaffairs.org/cgi/ content/full/hlthaff.w3.603v1/DC1 on 24 November 2004. [23] Lubitz J, Cai L, Kramarow E, Lentzner H. Health, life expectancy, and health care spending among the elderly. N Engl J Med. 2003;349:1048–55. [24] Zook CJ, Moore FD. High-cost users of medical care. N Engl J Med. 1980;302: 996–1002. [25] Brennan TA, Leape LL, Laird NM. Incidence of adverse events and negligence in hos- pitalized patients. Results of the Harvard Medical Practice Study I. N Engl J Med. 1991;324:370–6. [26] Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med. 1991;324: 377–84. [27] Localio AR, Lawthers AG, Brennan TA, et al. Relation between malpractice claims and adverse events due to negligence. Results of the Harvard Medical Practice Study III. N Engl J Med. 1991;325: 245–51. [28] Zhan C, Miller MR. Excess length of stay, charges and mortality attributable to me- dical injuries during hospitalization. JAMA 2003;290:1868–74. [29] Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Aca- demy Pr; 2001. [30] Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA 1997;277:307–11. [31] Bates DW, Leape LL, Cullen DJ, Laird N, Petersen LA, Teich JM, et al. Effect of com- puterized physician order entry and a team intervention on prevention of serious me- dication errors. JAMA 1998;280:1311–6. [32] Naylor CD editor. What is appropriate care? (Editorial). N Engl J Med 1998;338: 1918–20. [33] Shekelle PG editor. Are appropriateness criteria ready for use in clinical practice? (Editorial). N Engl J Med 2001;344:677–8. [34] Leape LL. Unnecessary surgery. Annu Rev Public Health 1992;13:363–83. [35] Emanuel EJ, Young-Xu Y, Levinsky NG, Gazelle G, Saynina O, Ash AS. Chemo- therapy use among Medicare beneficiaries at the end of life. Ann InterN Med 2003; 138:639–43. [36] Axene DV, Doyle RL, van der Burch D. Analysis of Medically Unnecessary Inpa- tient Services. New York: Milliman & Robertson; 1997. [37] Fischer MA, Avorn J. Economic implica- tions of evidence-based prescribing for hypertension: can better care cost less? JAMA 2004;291:1850–6. [38] Marques-Vidal P, Tuomilehto J. Hyperten- sion awareness, treatment and control in the community: is the ‘rule of halves’ still valid? Journal of human hypertension 1997;11:213–20. [39] O’Connor AM, Llewellyn-Thomas HA, Floor AB. Modifying unwarranted varia- tions in health care: shared decision making using patient decision aids. Health Affairs. Web Exclusive., 7. October 2004. VAR-63-72, Accessed at http:// content.healthaffairs.org/cgi/content/full/ hlthaff.var.63/DC2 on 24 November 2004. [40] Doran T, Fullwood C, Gravelle H, Reeves D, Kontopantelis E, Hiroeh U, et al. Pay-for- Performance Programs in Family Practices in the United Kingdom. N Engl J Med 2006;355:375–84. [41] Fisher ES, Davis K. Audio Interview: Pay for Performance – Recommendations of the Institute of Medicine. N Engl J Med 2006;355(13):e14. [42] Berenson RA. Does more health care spen- ding produce better health and happier doctors? Ann Intern Med 2006;144: 694–6. ARTICLE IN PRESS Dr. Christof Veit neuer Gescha ¨ ftsfu ¨ hrer der Bundesgescha ¨ ftsstelle Qualita ¨ tssicherung (BQS) Die Gesellschafterversammlung der Bundes- gescha ¨ ftsstelle Qualita ¨ tssicherung (BQS) hat Herrn Dr. Christof Veit mit Wirkung zum 15. Mai 2007 zum neuen Gescha ¨ ftsfu ¨ hrer der BQS berufen. Herr Dr. Veit leitete bisher die Landesgescha ¨ ftsstelle der Externen Qua- lita ¨ tssicherung (EQS) in Hamburg. Daneben ist er bisher Gescha ¨ ftsfu ¨ hrer der quant, Ser- vice fu ¨ r das Gesundheitswesen GmbH in Hamburg. Der Arzt Dr. Veit ist seit vielen Jahren auf Lan- desebene in die Umsetzung des BQS-Verfah- rens eingebunden, daneben wirkt er bisher in verschiedenen Gremien der BQS mit. Er ist daher mit der Materie bestens vertraut und genießt in der Branche hohe Akzeptanz. Nach Auffassung der Gesellschafter der BQS bringt Herr Dr. Christof Veit damit die besten Voraussetzungen mit, die bisherige hervorra- gende Arbeit der BQS fortzusetzen und dane- ben die BQS fu ¨ r die neuen ku ¨ nftigen Aufga- ben zu ru ¨ sten. Mit Blick auf das Vergabever- fahren zur U ¨ bernahme von Qualita ¨ tssiche- rungsaufgaben seitens des Gemeinsamen Bundesausschusses (G-BA) mu ¨ ssen die Schwerpunktaufgaben der BQS – die Verfah- rensentwicklung, die Durchfu ¨ hrung und Er- gebnisdarstellung der einrichtungsu ¨ bergrei- fenden Qualita ¨ tssicherung fu ¨ r Vertragsa ¨ rzte, fu ¨ r zugelassene Krankenha ¨ user und die sek- toru ¨ bergreifende Qualita ¨ tssicherung – neu fokussiert werden. Magazin Z.a ¨ rztl. Fortbild. Qual.Gesundh.wes. 101 (2007) 375–380 www.elsevier.de/zaefq 380

Post on 31-Oct-2016

214 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Dr. Christof Veit neuer Geschaeftsführer der Bundesgeschaeftsstelle Qualitaetssicherung (BQS)

Medicine National Roundtable on HealthCare Quality. JAMA 1998;280:1000–5.

[20] Ottorino C, Kimberly H, Carlson MD, BoydK, Buchter CM, Raiz P, et al. Impact of aGuideline-Based Disease ManagementTeam on Outcomes of HospitalizedPatients With Congestive Heart Failure.Arch Intern Med. 2001;161:177–82.

[21] Galbreath AD, Krasuski RA, Smith B,Stajduhar KC, Kwan MD, Ellis R, et al.Long-Term Healthcare and Cost Outcomesof Disease Management in a Large, Ran-domized, Community-Based PopulationWith Heart Failure. Circ. 2004;110:3518–26.

[22] Lieberman SM, Lee J, Anderson T, CrippenDL. Reducing the growth of Medicarespending: geographic versus patient-basedstrategies. Health Affairs. Web Exclusive.10 December 2003. W3-603-613. Acces-sed at http://content.healthaffairs.org/cgi/content/full/hlthaff.w3.603v1/DC1 on 24November 2004.

[23] Lubitz J, Cai L, Kramarow E, Lentzner H.Health, life expectancy, and health carespending among the elderly. N Engl J Med.2003;349:1048–55.

[24] Zook CJ, Moore FD. High-cost users ofmedical care. N Engl J Med. 1980;302:996–1002.

[25] Brennan TA, Leape LL, Laird NM. Incidenceof adverse events and negligence in hos-pitalized patients. Results of the HarvardMedical Practice Study I. N Engl J Med.1991;324:370–6.

[26] Leape LL, Brennan TA, Laird N, et al. Thenature of adverse events in hospitalized

patients. Results of the Harvard MedicalPractice Study II. N Engl J Med. 1991;324:377–84.

[27] Localio AR, Lawthers AG, Brennan TA,et al. Relation between malpractice claimsand adverse events due to negligence.Results of the Harvard Medical PracticeStudy III. N Engl J Med. 1991;325:245–51.

[28] Zhan C, Miller MR. Excess length of stay,charges and mortality attributable to me-dical injuries during hospitalization. JAMA2003;290:1868–74.

[29] Institute of Medicine. Crossing the QualityChasm: A New Health System for the 21stCentury. Washington, DC: National Aca-demy Pr; 2001.

[30] Bates DW, Spell N, Cullen DJ, et al. Thecosts of adverse drug events in hospitalizedpatients. Adverse Drug Events PreventionStudy Group. JAMA 1997;277:307–11.

[31] Bates DW, Leape LL, Cullen DJ, Laird N,Petersen LA, Teich JM, et al. Effect of com-puterized physician order entry and a teamintervention on prevention of serious me-dication errors. JAMA 1998;280:1311–6.

[32] Naylor CD editor. What is appropriatecare? (Editorial). N Engl J Med 1998;338:1918–20.

[33] Shekelle PG editor. Are appropriatenesscriteria ready for use in clinical practice?(Editorial). N Engl J Med 2001;344:677–8.

[34] Leape LL. Unnecessary surgery. Annu RevPublic Health 1992;13:363–83.

[35] Emanuel EJ, Young-Xu Y, Levinsky NG,Gazelle G, Saynina O, Ash AS. Chemo-therapy use among Medicare beneficiaries

at the end of life. Ann InterN Med 2003;138:639–43.

[36] Axene DV, Doyle RL, van der Burch D.Analysis of Medically Unnecessary Inpa-tient Services. New York: Milliman &Robertson; 1997.

[37] Fischer MA, Avorn J. Economic implica-tions of evidence-based prescribing forhypertension: can better care cost less?JAMA 2004;291:1850–6.

[38] Marques-Vidal P, Tuomilehto J. Hyperten-sion awareness, treatment and control inthe community: is the ‘rule of halves’ stillvalid? Journal of human hypertension1997;11:213–20.

[39] O’Connor AM, Llewellyn-Thomas HA,Floor AB. Modifying unwarranted varia-tions in health care: shared decisionmaking using patient decision aids. HealthAffairs. Web Exclusive., 7. October2004. VAR-63-72, Accessed at http://content.healthaffairs.org/cgi/content/full/hlthaff.var.63/DC2 on 24 November2004.

[40] Doran T, Fullwood C, Gravelle H, Reeves D,Kontopantelis E, Hiroeh U, et al. Pay-for-Performance Programs in Family Practicesin the United Kingdom. N Engl J Med2006;355:375–84.

[41] Fisher ES, Davis K. Audio Interview: Pay forPerformance – Recommendations of theInstitute of Medicine. N Engl J Med2006;355(13):e14.

[42] Berenson RA. Does more health care spen-ding produce better health and happierdoctors? Ann Intern Med 2006;144:694–6.

ARTICLE IN PRESS

Dr. Christof Veit neuer Geschaftsfuhrer der BundesgeschaftsstelleQualitatssicherung (BQS)

Die Gesellschafterversammlung der Bundes-geschaftsstelle Qualitatssicherung (BQS) hatHerrn Dr. Christof Veit mit Wirkung zum 15.Mai 2007 zum neuen Geschaftsfuhrer derBQS berufen. Herr Dr. Veit leitete bisher dieLandesgeschaftsstelle der Externen Qua-litatssicherung (EQS) in Hamburg. Danebenist er bisher Geschaftsfuhrer der quant, Ser-vice fur das Gesundheitswesen GmbH inHamburg.

Der Arzt Dr. Veit ist seit vielen Jahren auf Lan-desebene in die Umsetzung des BQS-Verfah-rens eingebunden, daneben wirkt er bisher inverschiedenen Gremien der BQS mit. Er istdaher mit der Materie bestens vertraut undgenießt in der Branche hohe Akzeptanz.Nach Auffassung der Gesellschafter der BQSbringt Herr Dr. Christof Veit damit die bestenVoraussetzungen mit, die bisherige hervorra-gende Arbeit der BQS fortzusetzen und dane-ben die BQS fur die neuen kunftigen Aufga-

ben zu rusten. Mit Blick auf das Vergabever-fahren zur Ubernahme von Qualitatssiche-rungsaufgaben seitens des GemeinsamenBundesausschusses (G-BA) mussen dieSchwerpunktaufgaben der BQS – die Verfah-rensentwicklung, die Durchfuhrung und Er-gebnisdarstellung der einrichtungsubergrei-fenden Qualitatssicherung fur Vertragsarzte,fur zugelassene Krankenhauser und die sek-torubergreifende Qualitatssicherung – neufokussiert werden.

Magazin

Z.arztl. Fortbild. Qual.Gesundh.wes. 101 (2007) 375–380www.elsevier.de/zaefq380